Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581412 · ClinicalTrials.gov registry record
Composite Graft Use in Abdominal Sacrocolpopexy Reduces Erosion Rates
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 60
- Enrollment target
NCT00581412: Completed study, sponsored by University of California, Irvine.
NCT00581412 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00581412 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This study is to determine whether the use of a composite biologic/synthetic graft during abdominal sacrocolpopexy leads to a lower rate of erosion while maintaining durability.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-04 |
What the finished NCT00581412 record still lists
NCT00581412 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00581412 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00581412 about?
NCT00581412 is a clinical study titled "Composite Graft Use in Abdominal Sacrocolpopexy Reduces Erosion Rates". This study is to determine whether the use of a composite biologic/synthetic graft during abdominal sacrocolpopexy leads to a lower rate of erosion while maintaining durability.
What is the current status of trial NCT00581412?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2007-09. Estimated completion is 2008-04.
Who is sponsoring clinical trial NCT00581412?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia